Spectral Medical Q3 swings to profit of CAD 5.1 million

Bitget2026/11/06 12:04

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Spectral Medical swung to third-quarter 2026 income of CAD 5.1 million from a year-earlier loss.
Revenue fell 59% year over year to CAD 275,000, partly due to the conclusion of the Vantive PrisMax substudy.
The FDA requested clarification, additional analyses and testing for PMX's approval application, but did not request another clinical trial.
Management expects recent convertible note financing to fund operations through the anticipated FDA decision.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spectral Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611060700PRIMZONEFULLFEED9872011) on November 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Spectral Medical Q3 swings to profit of CAD 5.1 million

You may also like

Crypto prices